04/24/2024 6:36 AM | Mereo BioPharma Group (Filer)
| Form ARS | |
04/24/2024 6:30 AM | Mereo BioPharma Group (Filer)
| Form DEF 14A | |
04/16/2024 1:58 PM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
04/15/2024 6:30 AM | Mereo BioPharma Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2024 4:20 PM | Mereo BioPharma Group (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 5:51 PM | Mereo BioPharma Group (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 1:11 PM | Mereo BioPharma Group (Subject) Rock Springs Capital Management LP (Filed by)
| Form SC 13G/A | |
|
02/14/2024 11:36 AM | MANGROVE PARTNERS IM, LLC (Filed by) Mereo BioPharma Group (Subject)
| Form SC 13G | |
02/13/2024 4:26 PM | Mereo BioPharma Group (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/05/2024 4:09 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Mereo BioPharma Group (Subject)
| Form SC 13G | |
01/23/2024 3:16 PM | Mereo BioPharma Group (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024 6:08 AM | Mereo BioPharma Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2024 3:16 PM | Hughes-Wilson Alexandra (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:17 PM | Mereo BioPharma Group (Issuer) Shames Daniel (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:18 PM | Mereo BioPharma Group (Issuer) Sermon Charles (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Bender Jeremy (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Mereo BioPharma Group (Issuer) Roberts Justin Hunter (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Mereo BioPharma Group (Issuer) Yoskowitz Marc J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Jacquet Pierre (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Mereo BioPharma Group (Issuer) WYZGA MICHAEL S (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Mereo BioPharma Group (Issuer) Scots-Knight Denise (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Lewicki John A. (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Jenkins Annalisa (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:15 PM | Fox Chrisitne Ann (Reporting) Mereo BioPharma Group (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:16 PM | Mereo BioPharma Group (Issuer) PAKIANATHAN DEEPIKA (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/18/2023 3:16 PM | Mereo BioPharma Group (Filer)
| Form 8-A12B/A | |
11/29/2023 3:15 PM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2023 7:45 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/16/2023 6:01 AM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2023 6:56 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/13/2023 6:31 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/08/2023 6:06 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/06/2023 6:30 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/02/2023 6:30 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
10/23/2023 3:08 PM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2023 6:01 AM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2023 3:03 PM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/07/2023 6:37 AM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 7:05 AM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2023 7:00 AM | Mereo BioPharma Group (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
06/07/2023 7:41 AM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
The Department of Defense Has a New Drone Contractor (Ad) The Department of Defense just granted a major advantage to a small UAV provider.
Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes. Click here to see how to invest |
05/22/2023 3:15 PM | Mereo BioPharma Group (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |